Advertisement

Complications of Endolumenal Bariatric Therapies (EBTs)

  • Emanuel Eguia
  • Bipan Chand
Chapter

Abstract

Endolumenal bariatric therapies continue to evolve and have become increasingly acceptable in the treatment of obesity and metabolic diseases. Each technique and therapy has its own degree and type of efficacy as well as its own spectrum of side effects and complications. It is vital that each EBT be closely evaluated and scrutinized prior to widespread adoption. Yet at the same time, it is imperative that more treatment options become available to patients and physicians as the obesity epidemic continues to prevail despite decades of recognizing the disease and its ravaging effects. The two preceding chapters dove into various endoluminal therapies and focused on results. This chapter will review side effects and complications of these modalities. As one reads through the chapter, it is important to keep into consideration that many of the devices and techniques are still in evolution and may continue to become more refined prior to commercialization and adoption. As such occurs, many of the adverse side effects and morbidity may decrease.

Keywords

Obesity Endolumenal bariatrics Endoluminal bariatrics Complications Bariatric surgery 

References

  1. 1.
    Gómez V, Woodman G, Abu Dayyeh BK. Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: results of a prospective study. Obesity. 2016;24:1849–53.CrossRefPubMedGoogle Scholar
  2. 2.
    Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19–27.CrossRefPubMedGoogle Scholar
  3. 3.
    Genco A, Bruni T, Doldi SB, Forestieri P, Marino M, Busetto L, Giardiello C, Angrisani L, Pecchioli L, Stornelli P, et al. BioEnterics Intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.CrossRefPubMedGoogle Scholar
  4. 4.
    De-Castrol ML, et al. Safety and effectiveness of gastric balloons associated with hypocaloric diet for the treatment of obesity. Rev Esp Enferm Dig (Madrid). 2013;105(9):529–36.CrossRefGoogle Scholar
  5. 5.
    Vargas AM, Fernandez NC, Ortega Serrano J. Preoperative weight loss in patients with indication of bariatric surgery: which is the best method? Nutr Hosp. 2011;26(6):1227–30.Google Scholar
  6. 6.
    Zeman RK, Benjamin SB, Cunningham MB, et al. Small bowel obstruction due to Garren gastric bubble: radiographic diagnosis. AJR Am J Roentgenol. 1988;150:581–2.CrossRefPubMedGoogle Scholar
  7. 7.
    US Food and Drug Administration. Summary of safety and effectiveness data (SSED) ORBERA Intragastric Balloon System. 2015. p. 1–32. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140008b.pdf
  8. 8.
    Kumar N, Bazerbachi F, Rustagi T, McCarty TR, Thompson CC, Galvao Neto MP, et al. The influence of the Orbera Intragastric balloon filling volumes on weight loss, tolerability, and adverse events: a systematic review and meta-analysis. Obes Surg. 2017;27(9):2272–8. [Epub ahead of print]CrossRefPubMedGoogle Scholar
  9. 9.
    US Food and Drug Administration. Summary of safety and effectiveness data (SSED) ReShape Integrated Dual Balloon System. 2015. p. 1–43. https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140012b.pdf
  10. 10.
    US Food and Drug Administration. Summary of safety and effectiveness data (SSED): Obalon Balloon System. 2016. p. 1–46. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160001b.pdf
  11. 11.
    Sauer N, Rosch T, Pezold J, Reining F, Anders M, Groth S, et al. A new endoscopically implantable device (SatiSphere) for treatment of obesity–efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels. Obes Surg. 2013;23(11):1727–33.CrossRefPubMedGoogle Scholar
  12. 12.
    Schwartz MP, Wellink H, Gooszen HG, Conchillo JM, Samsom M, Smout AJ. Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut. 2007;56:20–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Mahmood Z, McMahon BP, Arfin Q, Byrne PJ, Reynolds JV, Murphy EM, Weir DG. Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut. 2003;52:34–9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Rothstein RI, Filipi CJ. Endoscopic suturing for gastroesophageal reflux disease: clinical outcome with the Bard EndoCinch. Gastrointest Endosc Clin N Am. 2003;13:89–101.CrossRefPubMedGoogle Scholar
  15. 15.
    Fogel R, De Fogel J, Bonilla Y, De La Fuente R. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc. 2008;68:51–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Brethauer SA, Chand B, Schauer PR, et al. Transoral gastric volume reduction as intervention for weight management: 12 month follow up of TRIM trial. Surg Obes Relat Dis. 2012;8(3):296–303.CrossRefPubMedGoogle Scholar
  17. 17.
    Kumar N. Weight loss endoscopy: development, applications, and current status. World J Gastroenterol. 2016;22(31):7069–79.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Fujii LL, Bonin EA, Baron TH, Gostout CJ, Wong Kee Song LM. Utility of an endoscopic suturing system for prevention of covered luminal stent migration in the upper GI tract. Gastrointest Endosc. 2013;78:787–93.CrossRefPubMedGoogle Scholar
  19. 19.
    Kumar N, Thompson CC. A novel method for endoscopic perforation management by using abdominal exploration and full-thickness sutured closure. Gastrointest Endosc. 2014;80:156–61.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Lopez-Nava G, Sharaiha RZ, Galvao Neto M, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 242 patients with 18 months follow-up. Gastroenterology. 2016;150(4S1):S26.CrossRefGoogle Scholar
  21. 21.
    Abu Dayyeh BK, Acosta A, Camilleri M, Mundi MS, Rajan E, Topazian MD, Gostout CJ. Endoscopic sleeve Gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017;15(1):37–43.e1.CrossRefPubMedGoogle Scholar
  22. 22.
    Espinos JC, Turro R, Mata A, Cruz M, da Costa M, Villa V, et al. Early experience with the Incisionless operating platform (IOP) for the treatment of obesity : the primary obesity surgery Endolumenal (POSE) procedure. Obes Surg. 2013;23(9):1375–83.CrossRefPubMedGoogle Scholar
  23. 23.
    Espinós JC, Turró R, Moragas G, et al. Gastrointestinal physiological changes and their relationship to weight loss following the pose procedure. Obes Surg. 2016;26:1081–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Sullivan S, Swain JM, Woodman G, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity (Silver Spring). 2017;25:294–301.CrossRefGoogle Scholar
  25. 25.
    Devière J, Ojeda Valdes G, Cuevas Herrera L, Closset J, Le Moine O, Eisendrath P, Moreno C, Dugardeyn S, Barea M, de la Torre R, et al. Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg Endosc. 2008;22:589–98.CrossRefPubMedGoogle Scholar
  26. 26.
    Moreno C, Closset J, Dugardeyn S, Baréa M, Mehdi A, Collignon L, Zalcman M, Baurain M, Le Moine O, Devière J. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy. 2008;40:406–13.CrossRefPubMedGoogle Scholar
  27. 27.
    Familiari P, Costamagna G, Blero D, Le Moine O, Perri V, Boskoski I, et al. Transoral gastroplasty for morbid obesity; a multicenter trial with 1 year outcome. Gatrointest Endosc. 2011;74(6):1248–58.CrossRefGoogle Scholar
  28. 28.
    Biertho L, Hould FS, Lebel S, Biron S. Transoral endoscopic restrictive implant system: a new endoscopic technique for the treatment of obesity. Surg Obes Relat Dis. 2010;6:203–5.CrossRefPubMedGoogle Scholar
  29. 29.
    G M, C E, V RM, F G. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg Obes Relat Dis. 2014;10(5):929–34.CrossRefGoogle Scholar
  30. 30.
    Rodriguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, Tarnoff M. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4:55–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Tarnoff M, Rodriguez L, Escalona A, Ramos A, Neto M, Alamo M, Reyes E, Pimentel F, Ibanez L. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc. 2009;23:650–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Schouten R, Rijs CS, Bouvy ND, al e. A multicenter, randomized efficacy study of the EndoBarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251:236–43.CrossRefPubMedGoogle Scholar
  33. 33.
    Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425–438.e5.CrossRefPubMedGoogle Scholar
  34. 34.
    ValenTx Endo Bypass System: initial trial. 2009. www.valentx.com/news-1.php. Accessed 1 Aug 2014.
  35. 35.
    Ryou M, Ryan MB, Thompson CC. Current status of endoluminal bariatric procedures for primary and revision indications. Gastrointest Endosc Clin N Am. 2011;21:315–33.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Sandler BJ, Rumbaut R, Swain CP, et al. Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve. Surg Endosc. 2011;25:3028–33.CrossRefPubMedGoogle Scholar
  37. 37.
    Ryou M, Cantillon-Murphy P, Azagury D, Shaikh SN, Ha G, Greenwalt I, Ryan MB, Lang JH, Thompson CC. Smart self-assembling MagnetS for ENdoscopy (SAMSEN) for transoral endoscopic creation of immediate gastrojejunostomy (with video). Gastrointest Endosc. 2011;73:353–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Ryou M, Agoston AT, Thompson CC. Endoscopic intestinal bypass creation by using self-assembling magnets in a porcine model. Gastrointest Endosc. 2016;83:821–5.CrossRefPubMedGoogle Scholar
  39. 39.
    Ryou M, Aihara H, Thompson CC. Minimally invasive entero-enteral dual-path bypass using self-assembling magnets. Surg Endosc. 2016;30(10):4533–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Machytka E, Buzga M, Ryou MK, Lautz DB, Thompson CC. Endoscopic dual-path enteral anastomosis using self-assembling magnets: first-in-human clinical feasibility. Gastroenterology. 2016;150:S232.CrossRefGoogle Scholar
  41. 41.
    Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology. 2017;152(7):1791–801.CrossRefPubMedGoogle Scholar
  42. 42.
    Forssell H, Norén E. A novel endoscopic weight loss therapy using gastric aspiration: results after 6 months. Endoscopy. 2015;47:68–71.CrossRefPubMedGoogle Scholar
  43. 43.
    Thompson CC, Abu Dayyeh BK, Kushner K, Sullivan S, Schorr AB, Amaro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD. The AspireAssist is an effective tool in the treatment of class II and class III obesity: results of a one-year clinical trial. Gastroenterology. 2016;4:S86.CrossRefGoogle Scholar
  44. 44.
    Sullivan S, Stein R, Jonnalagadda S, et al. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology. 2013;145:1245–1252.e5.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    US Food and Drug Administration. Summary of safety and effectiveness data (SSED): AspireAssist FDA, ed. 2016. p. 1–36. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf15/p150024b.pdf
  46. 46.
    Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59.CrossRefPubMedGoogle Scholar
  47. 47.
    Allen JW. Laparoscopic gastric band complications. Med Clin North Am. 2007;91:485–97. xii.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of SurgeryLoyola University Medical CenterMaywoodUSA

Personalised recommendations